Access the full text.
Sign up today, get DeepDyve free for 14 days.
R. Broaddus, P. Lynch, K. Lu, R. Luthra, S. Michelson (2004)Unusual tumors associated with the hereditary nonpolyposis colorectal cancer syndrome
Modern Pathology, 17
J. González-Aguilera, Nargisse Nejda, F. Fernández, V. Medina, F. González-Hermoso, Y. Barrios, M. Azcoita, A. Fernández-Peralta (2003)Genetic Alterations and MSI Status in Primary, Synchronous, and Metachronous Tumors in a Family With Hereditary Nonpolyposis Colorectal Cancer (HNPCC)
American Journal of Clinical Oncology, 26
HT Lynch, A la Chapelle (2003)Genomic medicine: hereditary colon cancer
N Engl J Med, 348
G. Obmolova, C. Ban, P. Hsieh, Wei Yang (2000)Crystal structures of mismatch repair protein MutS and its complex with a substrate DNA
H. Vasen, Mecklin Jp, P. Khan, H. Lynch (1991)The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC)
Diseases of the Colon & Rectum, 34
L. Hung, I. Wang, K. Nikaido, Pei‐Qi Liu, G. Ames, Sung-Hou Kim (1998)Crystal structure of the ATP-binding subunit of an ABC transporter
K. Drotschmann, A. Clark, H. Tran, Michael Resnick, Dmitry Gordenin, Thomas Kunkel (1999)Mutator phenotypes of yeast strains heterozygous for mutations in the MSH2 gene.
Proceedings of the National Academy of Sciences of the United States of America, 96 6
P. Watson, H. Lynch (1993)Extracolonic cancer in hereditary nonpolyposis colorectal cancer
H. Vasen, P. Watson, J. Mecklin, H. Lynch (1999)New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC.
Gastroenterology, 116 6
C. Thornton, K. Johnson, R. Moxley (1994)Myotonic dystrophy patients have larger CTG expansions in skeletal muscle than in leukocytes
Annals of Neurology, 35
M. Walsh, D. Buchanan, M. Cummings, Sally-Ann Pearson, S. Arnold, M. Clendenning, Rhiannon Walters, D. McKeone, A. Spurdle, J. Hopper, M. Jenkins, K. Phillips, G. Suthers, Jill George, J. Goldblatt, A. Muir, K. Tucker, E. Pelzer, M. Gattas, S. Woodall, S. Parry, F. Macrae, R. Haile, J. Baron, J. Potter, L. Marchand, B. Bapat, S. Thibodeau, N. Lindor, M. McGuckin, Joanne Young (2010)Lynch Syndrome–Associated Breast Cancers: Clinicopathologic Characteristics of a Case Series from the Colon Cancer Family Registry
Clinical Cancer Research, 16
B. Studamire, Tony Quach, E. Alani (1998)Saccharomyces cerevisiae Msh2p and Msh6p ATPase Activities Are Both Required during Mismatch Repair
Molecular and Cellular Biology, 18
M. Berends, A. Cats, H. Hollema, A. Karrenbeld, J. Beentjes, R. Sijmons, R. Mensink, R. Hofstra, R. Verschueren, J. Kleibeuker (2000)Adrenocortical adenocarcinoma in an MSH2 carrier: coincidence or causal relation?
Human pathology, 31 12
H. Lynch, J. Lynch (2000)Lynch syndrome: genetics, natural history, genetic counseling, and prevention.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 18 21 Suppl
Te-hui Wu, M. Marinus (1994)Dominant negative mutator mutations in the mutS gene of Escherichia coli
Journal of Bacteriology, 176
Peter Beighton, Greta Beighton (1997)de la Chapelle, A.
V. Medina‐Arana, Y. Barrios, A. Fernández-Peralta, Alejandro Jiménez, E. Salido, F. González, J. González-Aguilera (2004)Tumour spectrum of non-polyposis colorectal cancer (Lynch syndrome) on the island of Tenerife and influence of insularity on the clinical manifestations
European Journal of Cancer Prevention, 13
R. Post, L. Kiemeney, Marjolein Ligtenberg, J. Witjes, C. Kaa, D. Bodmer, L. Schaap, C. Kets, J. Krieken, N. Hoogerbrugge (2010)Risk of urothelial bladder cancer in Lynch syndrome is increased, in particular among MSH2 mutation carriers
Journal of Medical Genetics, 47
V. Medina‐Arana, Y. Barrios, A. Fernández-Peralta, M. Herrera, Nancy Chinea, Nieves Lorenzo, Alejandro Jiménez, Juana Martín-López, F. González-Hermoso, E. Salido, J. González-Aguilera (2006)New founding mutation in MSH2 associated with hereditary nonpolyposis colorectal cancer syndrome on the Island of Tenerife.
Cancer letters, 244 2
C. Boland, S. Thibodeau, S. Hamilton, D. Sidransky, J. Eshleman, R. Burt, S. Meltzer, M. Rodriguez-Bigas, R. Fodde, G. Ranzani, S. Srivastava (1998)A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer.
Cancer research, 58 22
A. Gorbalenya, E. Koonin (1990)Superfamily of UvrA-related NTP-binding proteins. Implications for rational classification of recombination/repair systems.
Journal of molecular biology, 213 4
K Drotschmann, AB Clark, HT Tran (1999)Mutator phenotypes of yeast strains heterozygous for mutations in the MSH2 gene
Proc Natl Acad Sci USA, 96
H. Hampel, J. Stephens, E. Pukkala, R. Sankila, L. Aaltonen, J. Mecklin, A. Chapelle (2005)Cancer risk in hereditary nonpolyposis colorectal cancer syndrome: later age of onset.
Gastroenterology, 129 2
V. Arana, Y. Pino, C. García-Castro, J. González-Aguilera, A. Fernández-Peralta, F. Hermoso (2002)Highly aggressive leiomyosarcoma associated with Lynch II syndrome: increasing the range of extracolonic cancers related with hereditary non-polyposis colonic cancer.
Annals of oncology : official journal of the European Society for Medical Oncology, 13 5
R. Sijmons, R. Hofstra, H. Hollema, R. Mensink, A. Hout, H. Hoekstra, J. Kleibeuker, W. Molenaar, J. Wijnen, R. Fodde, H. Vasen, C. Buys (2000)Inclusion of malignant fibrous histiocytoma in the tumour spectrum associated with hereditary non‐polyposis colorectal cancer
M. Gomes-Pereira, M. Fortune, D. Monckton (2001)Mouse tissue culture models of unstable triplet repeats: in vitro selection for larger alleles, mutational expansion bias and tissue specificity, but no association with cell division rates.
Human molecular genetics, 10 8
H. Lynch, A. Chapelle (2003)Hereditary colorectal cancer.
The New England journal of medicine, 348 10
P. Watson, H. Vasen, J. Mecklin, I. Bernstein, M. Aarnio, H. Järvinen, T. Myrhøj, L. Sunde, J. Wijnen, H. Lynch (2008)The risk of extra‐colonic, extra‐endometrial cancer in the Lynch syndrome
International Journal of Cancer, 123
Lynch syndrome (LS) is an autosomal dominant condition that predisposes to colorectal cancer and specific other tumors. Extracolonic tumors occur mainly in the endometrium, stomach, ovary, small intestine and urinary tract. The presence of rare tumors in patients belonging to families who have Lynch syndrome is always interesting, because the question arises whether these tumors should be considered as a coincidence or are related with the syndrome. In this last case, they are also the result of the defect in the mismatch repair system, opening the possibility of extending the tumor spectrum associated with the syndrome. Here we describe a patient from a Lynch syndrome family with a germline mutation c.2063T>G (p.M688R) in the MSH2 gene, who developed an adrenal cortical carcinoma, a tumor not usually associated with LS. We analyzed the adrenocortical tumour for microsatellite instability (MSI), LOH and the presence of the germline c.2063T>G (M688R) mutation. The adrenal cortical carcinoma showed the MSH2 mutation, loss of heterozygosity of the normal allele in the MSH2 gene and loss of immunohistochemical expression for MSH2 protein, but no microsatellite instability. Additionally, the adrenal cortical carcinoma did not harbour a TP53 mutation. The molecular study indicates that this adrenal cortical cancer is probably due to the mismatch repair defect.
Familial Cancer – Springer Journals
Published: Jan 12, 2011
Access the full text.
Sign up today, get DeepDyve free for 14 days.